Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I–III Triple-Negative Breast Cancer

被引：0
|
作者：
Carolyn Hall
Mandar Karhade
Barbara Laubacher
Amber Anderson
Henry Kuerer
Sarah DeSynder
Anthony Lucci
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology, Unit 444
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Overall Survival; Circulate Tumor Cell; Axillary Lymph Node Status; Primary Tumor Size; TNBC Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：552 / 558
页数：6
相关论文
共 50 条
  • [1] Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer
    Hall, Carolyn
    Karhade, Mandar
    Laubacher, Barbara
    Anderson, Amber
    Kuerer, Henry
    DeSynder, Sarah
    Lucci, Anthony
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S552 - S558
  • [2] Circulating Tumor Cells after Neoadjuvant Therapy in Stage I-III Triple-negative Breast Cancer
    Hall, C.
    Laubacher, B.
    Anderson, A.
    Karhade, M.
    Kuerer, H. M.
    DeSnyder, S.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S17 - S17
  • [3] Profile of circulating natural killer cells in stage III triple negative breast cancer before and after neoadjuvant chemotherapy
    Batista, Luiz Jose de Barros
    Telles, Jurema
    Santos, Candice
    Souza, Ariani
    Salgado, Marcelo
    Torres, Leuridan
    CANCER RESEARCH, 2024, 84 (09)
  • [4] Circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Lucci, A.
    Hall, C.
    Hess, K.
    Ravenberg, E.
    Clayborn, A.
    Mittendorf, E.
    Rauch, G.
    Candelaria, R.
    Moulder, S.
    Thompson, A.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030
    Parsons, H. A.
    Blewett, T.
    Chu, X.
    Sridhar, S.
    Santos, K.
    Xiong, K.
    Abramson, V. G.
    Patel, A.
    Cheng, J.
    Brufsky, A.
    Rhoades, J.
    Force, J.
    Liu, R.
    Traina, T. A.
    Carey, L. A.
    Rimawi, M. F.
    Miller, K. D.
    Stearns, V.
    Specht, J.
    Falkson, C.
    Burstein, H. J.
    Wolff, A. C.
    Winer, E. P.
    Tayob, N.
    Krop, I. E.
    Markrigiorgos, G. M.
    Golub, T. R.
    Mayer, E. L.
    Adalsteinsson, V. A.
    ANNALS OF ONCOLOGY, 2023, 34 (10) : 899 - 906
  • [6] Prognostic implications of circulating tumor cells (CTCs) after neoadjuvant chemotherapy for triple negative breast cancer (TNBC)
    Hall, C.
    Hess, R.
    Ravenberg, L.
    Clayborn, A.
    Rauch, G. M.
    Candelaria, R.
    Mittendorf, E. A.
    Moulder, S. L.
    Thompson, A.
    Lucci, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Extent of Breast Surgery After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
    Ponzone, Riccardo
    Montemurro, Filippo
    JAMA SURGERY, 2020, 155 (08) : 785 - 786
  • [8] CIRCULATING TUMOR CELLS AFTER NEOADJUVANT THERAPY AND RELAPSE IN STAGE I-III BREAST CANCER
    Hall, C.
    Valad, L.
    Karhade, M.
    Bauldry, J.
    Kuerer, H.
    DeSnyder, S.
    Lucci, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 122 - 122
  • [9] Circulating Tumor Cells After Neoadjuvant Therapy and Relapse in Stage I-III Breast Cancer
    Hall, C.
    Valad, L.
    Bauldry, J.
    Karhade, M.
    Kuerer, H. M.
    DeSnyder, S. M.
    Barcenas, C. H.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S15 - S15
  • [10] The prognostic role of circulating tumor DNA after neoadjuvant chemotherapy in triple negative breast cancer with residual tumor
    Roseshter, Talia
    Klemantovich, Anna
    Cavallone, Luca
    Aguilar-Mahecha, Adriana
    Lafleur, Josiane
    Elebute, Oluwadara O.
    Jenna, Sarah
    Boileau, Jean-Francois
    Pelmus, Manuela
    Basik, Mark
    Lan, Cathy
    CANCER RESEARCH, 2023, 83 (05)
12345